Until she was thirty-three, Kathryn Paige Harden, a professor of psychology at the University of Texas at Austin, had enjoyed a vocational ascent so steady that it seemed guided by the hand of ...

Shares of Ultragenyx Pharmaceutical RARE were up 15.5% yesterday following the completion of the rolling submission of a ...

Researchers studied 91 stress-response genes in a sweet potato relative, identifying potential roles in drought and disease ...

For most people, the loss of a sense such as sight is devastating, not only for intensifying vulnerability, but for ...

Ultragenyx Pharmaceutical ( ($RARE) ) just unveiled an update. On December 30, 2025, Ultragenyx Pharmaceutical announced it had completed the ...

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...

GE HealthCare Technologies Inc. (NYSE: GEHC) leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using ...

With a new year just days away, we hope the following list of the top 10 patents of 2025 sparks interest in the state of ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) ...